CIK 0001818382
- Non-accelerated filer
- Smaller reporting company
Humacyte, Inc.
Sign in to watch- Ticker
- HUMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 851763759
- Phone
- +1 919-313-9633
- Business address
- 2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM, NC, 27713
- Former names
- Alpha Healthcare Acquisition Corp.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale President, CEO and Director sold 500,000 shares at $3.12 ($1,558,750)
- 4 Open-market sale Director sold 500,000 shares at $3.12 ($1,558,750)
- 4 Open-market sale 10% owner sold 500,000 shares at $3.12 ($1,558,750)
- 4 Open-market sale President, CEO and Director sold 4,875,000 shares at $2.60 ($12,675,000)
- 4 Open-market sale Director sold 4,875,000 shares at $2.60 ($12,675,000)
- 4 Open-market sale 10% owner sold 4,875,000 shares at $2.60 ($12,675,000)
- 4 Open-market sale President, CEO and Director sold 2,625,000 shares at $2.75 ($7,218,750)
- 4 Open-market sale Chief Operating Officer sold 23,402 shares at an average $4.01 ($93,904)
- 4 Open-market sale Director sold 2,625,000 shares at $2.75 ($7,218,750)
- 4 Open-market sale 10% owner sold 2,625,000 shares at $2.75 ($7,218,750)
- 4 Open-market buy Director bought 4,750 shares at $4.18 ($19,855)
- 4 Exercise or conversion Director acquired 100,000 shares (option exercise)
- 4 Exercise or conversion President, CEO and Director acquired 100,000 shares (option exercise)
Page 7 of 12 · 235 filings